Nordisk

Initial prescriptions for the drug are expected to be issued in Shanghai this week, Yicai news service reported on Monday. Wegovy is also listed as available for pre-orders on several e-commerce platforms where patients can register…

(Reuters) - Danish drugmaker Novo Nordisk (NYSE:) has mitigation plans to reduce or prevent any interruptions in its production due to U.S. seaport strikes, CNBC reported on Tuesday, citing a company spokesperson. The report added that…

(Reuters) - Novo Nordisk (NYSE:) CEO Lars Jorgensen has agreed to voluntarily testify at a hearing focusing on U.S. prices for weight-loss drugs Ozempic and Wegovy, the Senate Committee on Health, Education, Labor and Pensions said on…

WASHINGTON (Reuters) - The U.S. Senate Health Committee said on Tuesday it will vote this month on whether to subpoena Novo Nordisk (NYSE:) to answer questions about U.S. prices for weight-loss drugs Ozempic and Wegovy, which are much…

jetcityimage Eli Lilly shares (New York Stock Exchange: LLY) and Novo Nordisk (NVO) in recent months, driven by growing demand for the companies' weight-loss/diabetes drugs tirzepatide, also known as Mounjaro and Zepbound, and…

Weight loss translates into profits for investors. Just look at Eli Lilly And Novo Nordisk. Both stocks have risen dramatically thanks in large part to their obesity drugs, with Lilly's stock more than quadrupling and Novo's…

Novo Nordisk A/S raised its earnings forecast as the drugmaker now ships five times more introductory doses of the weight-loss drug Wegovy in the US than at the end of last year. More than 25,000 patients are now starting treatment each…

(Correcting to remove reference to sales, profit forecast in paragraph 1 being a record)COPENHAGEN/LONDON (Reuters) -Novo Nordisk on Wednesday forecast another year of double-digit sales and operating profit growth as it began easing…

© Reuters. FILE PHOTO: A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo By Patrick Wingrove…

© Reuters. FILE PHOTO: A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo By Maggie Fick LONDON…